ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

LMU University Hospital Munich at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

LMU University Hospital Munich takes part in 13 sessions at ESMO 2026 in Madrid. Its program covers breast, ovarian, kidney, and lung cancers, alongside molecular testing and treatment across tumour types. Specific topics include breast cancer outcomes, biomarkers for kidney cancer treatment, and sequencing tumour samples.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Teaching hospital of Ludwig-Maximilians-Universität München, in Munich, Germany.
Poster
Fri Oct 23
13:00–15:00
Epigenetic targeting of KAT6 in breast cancer and solid tumors
ePoster session 10
Breast cancer
Poster
Fri Oct 23
15:15–16:00
Erythropoietin suppression as a biomarker for HIF2α inhibitors in clear cell renal cell carcinoma
Friday Poster Display session 5
Genitourinary cancersSarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Talk
Sat Oct 24
09:30–09:50
Overcoming regulatory barriers of clinical trials
Solutions to overcome barriers of access to clinical trials
Talk
Sun Oct 25
09:00
Tumour-agnostic therapies
YO Clinical case discussions · with University of Cambridge
Talk
Sun Oct 25
10:30–10:45
The role of the oncologist in coordination of multi-omic molecular diagnostics
ESMO-ASCO: The evolving definition of the modern oncologist
Poster
Sun Oct 25
12:00–12:45
Placebo effect in oncology: Tumor response to placebo in randomized cancer trials
Sunday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancersBreast cancerMelanoma & skin cancersGenitourinary cancersGastrointestinal cancersHaematological malignanciesGynaecological cancers
Poster
Sun Oct 25
12:00–12:45
Chair
Mon Oct 26
10:15–11:30
Optimal management of high-grade serous ovarian cancer with BRCA mutation
with Centre Léon Bérard
Gynaecological cancers
Talk
Mon Oct 26
10:20–10:40
Surgery and first-line systemic therapy: How to choose among the different options?
Optimal management of high-grade serous ovarian cancer with BRCA mutation
Gynaecological cancers
Poster
Mon Oct 26
12:00–12:45
Chair
Mon Oct 26
12:00–12:50
What oncologists should know about interpreting tumour sequencing
with The Royal Marsden, Memorial Sloan Kettering Cancer Center
Biomarkers & precision oncology
Talk
Mon Oct 26
12:30–12:45
Interpreting low-risk germline variants
What oncologists should know about interpreting tumour sequencing
Biomarkers & precision oncology
Chair
Mon Oct 26
14:45–16:15
Tumour-agnostic oncology: From concept to clinical practice
Biomarkers & precision oncology
Talk
Tue Oct 27
12:20–12:40
Investigational immunotherapy
Scientific Congress Highlights 2

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at LMU University Hospital Munich

Tell us what you sell and we’ll find the people at LMU University Hospital Munich most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction